NUKOVAX 13

NUKOVAX 13 - Protect Your Infant from Pneumococcal Disease

Ensure your baby's health and safety with NUKOVAX 13, a pneumococcal conjugate vaccine developed in China, procured by G.C. Chemie Pharmie Ltd, and remarketed by Lupin. Trusted by healthcare professionals, NUKOVAX 13 offers robust protection against pneumococcal disease, which can lead to severe infections such as pneumonia, meningitis, and bloodstream infections.

Key Benefits:

✅ Comprehensive Protection – Safeguards infants against 13 strains of pneumococcal bacteria.

✅ Clinically Proven – Supported by rigorous clinical trials and approved by global health authorities.

✅ Safe and Effective – Known for its high efficacy and low incidence of side effects.

✅ Essential for Infants – Recommended only for babies under 1 year of age to provide early and effective protection.

✅ Meets Pediatric Guidelines – Complies with immunization schedules for infants as per global health recommendations.

Active Compound:

The active ingredient in NUKOVAX 13 is a pneumococcal polysaccharide conjugate vaccine. It contains purified capsular polysaccharides from 13 strains of Streptococcus pneumoniae (pneumococcus). These polysaccharides are conjugated to a tetanus toxoid (TT) protein, which enhances the immune response, making the vaccine highly effective in young infants.

Polysaccharides:

🔹 Derived from the capsules of 13 different serotypes of Streptococcus pneumoniae.
🔹 These serotypes are: 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F.

Carrier Protein (Tetanus Toxoid - TT):

🔹 A highly purified and non-toxic form of the tetanus protein, used to enhance the immune system's response to the polysaccharides.
🔹 This conjugation ensures a strong and long-lasting immune response, particularly in infants under 1 year of age.

Schedule and Dosage:

📌 Age Group: Only for infants under 1 year of age.
📌 Dosage: 3 doses.
📌 Timing: Administered at 2 months, 4 months, and 6 months of age.

What to Expect:

💉 Common Side Effects: Mild reactions including redness or swelling at the injection site, low-grade fever, and fussiness.

🩹 Post-Vaccination Care: Use a cool compress on the injection site to alleviate any discomfort and monitor for any unusual reactions.

Why Choose NUKOVAX 13?

✅ Expert Recommendation – Endorsed by pediatricians for its reliability and effectiveness in infants.

✅ Innovative Technology – Uses tetanus toxoid (TT) as a carrier protein, ensuring a robust immune response.

✅ Global Collaboration – Developed in collaboration with a trusted source in China, adhering to international quality standards.

✅ Peace of Mind – Provides parents with confidence in their baby’s health and well-being.

Give your baby the best start in life with NUKOVAX 13, a vaccine designed exclusively for infants under 1 year of age to provide early and effective protection against pneumococcal disease.